A drug used to prevent the rejection of transplanted organs and as an experimental cancer treatment in humans can significantly increase lifespan when given to adult mice, researchers have found. Mice that were administered the immunosuppressant rapamycin lived an average of 9-14% longer than mice that were not fed the drug, according to a paper published online in __Nature__ today (July 8th).
"This is pretty remarkable," linkurl:Panjak Kapahi,;http://www.buckinstitute.org/TheScience/KapahiLab/ a geneticist at the Buck Institute for Age Research in California told __The Scientist__. "There might be more to gain in understanding the downstream effects, but this is already a wonderful start." Kapahi, who was not involved with the study, added that, though preliminary, the finding opens the door for further research into the drug's use for an anti-aging intervention in humans. "It should be applicable to humans, I think." linkurl:David Harrison,;http://research.jax.org/faculty/david_harrison.html...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?